1. A Nanomedicine Fabricated from Gold Nanoparticles‐Decorated Metal–Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy. Issue 17 (14th June 2020) Authors: Ding, Yuan; Xu, Hao; Xu, Chang; Tong, Zongrui; Zhang, Sitong; Bai, Yang; Chen, Yining; Xu, Qianhui; Zhou, Liuzhi; Ding, Hao; Sun, Zhongquan; Yan, Sheng; Mao, Zhengwei; Wang, Weilin Journal: Advanced science Issue: Volume 7:Issue 17(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cepharanthine Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Mice via Inhibiting 15-Lipoxygenase-1-Mediated Microglia and Endothelial Cell Ferroptosis. (9th February 2022) Authors: Gao, Shiqi; Zhou, Liuzhi; Lu, Jianan; Fang, Yuanjian; Wu, Haijian; Xu, Weilin; Pan, Yuanbo; Wang, Junjie; Wang, Xiaoyu; Zhang, Jianmin; Shao, Anwen Other Names: Tang Hailiang Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma. (7th June 2021) Authors: Ding, Yuan; Sun, Zhongquan; Zhang, Sitong; Li, Yanjie; Han, Xin; Xu, Qianhui; Zhou, Liuzhi; Xu, Hao; Bai, Yang; Xu, Chang; Ding, Hao; Ge, Yao; Wang, Weilin Other Names: Ghorbani Morteza Academic Editor. Journal: BioMed research international Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of snoRNA SNORA71A as a Novel Biomarker in Prognosis of Hepatocellular Carcinoma. (27th September 2020) Authors: Ding, Yuan; Sun, Zhongquan; Zhang, Sitong; Zhou, Liuzhi; Xu, Qianhui; Zhou, Dongkai; Li, Yanjie; Han, Xin; Xu, Hao; Bai, Yang; Xu, Chang; Ding, Hao; Ge, Yao; Wang, Weilin Other Names: Theocharis Stamatios E. Academic Editor. Journal: Disease markers Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients. (27th May 2022) Authors: Zhang, Xiaohe; Li, Hongbo; Zhou, Liuzhi; Wu, Di; Zhou, Shixiang; Yang, Yao; Hu, Yabin Other Names: Ding Xiangya Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Nanomedicine: A Nanomedicine Fabricated from Gold Nanoparticles‐Decorated Metal–Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy (Adv. Sci. 17/2020). Issue 17 (9th September 2020) Authors: Ding, Yuan; Xu, Hao; Xu, Chang; Tong, Zongrui; Zhang, Sitong; Bai, Yang; Chen, Yining; Xu, Qianhui; Zhou, Liuzhi; Ding, Hao; Sun, Zhongquan; Yan, Sheng; Mao, Zhengwei; Wang, Weilin Journal: Advanced science Issue: Volume 7:Issue 17(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Preclinical validation of silibinin/albumin nanoparticles as an applicable system against acute liver injury. (1st July 2022) Authors: Ding, Yuan; Zhang, Sitong; Sun, Zhongquan; Tong, Zongrui; Ge, Yao; Zhou, Liuzhi; Xu, Qianhui; Zhou, Huiping; Wang, Weilin Journal: Acta biomaterialia Issue: Volume 146(2022) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Issue 7 (22nd July 2020) Authors: Ding, Yuan; Sun, Zhongquan; Zhang, Sitong; Xu, Qianhui; Zhou, Liuzhi; Zhou, Dongkai; Li, Yanjie; Han, Xin; Xu, Hao; Bai, Yang; Xu, Chang; Ding, Hao; Ge, Yao; Wang, Weilin Journal: Bioscience reports Issue: Volume 40:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗